Market requirements · EE
Estonia
Ravimiamet published a dated statement in June 2026 addressing internet-sold peptides marketed for research, naming semaglutide and tirzepatide directly.
| Tell us the compounds you need for Estonia. | Ask about Estonia |
The regime
How compounds are classified in Estonia
| Governing law and regulator | Estonian medicines are governed by the Ravimiseadus (Medicinal Products Act) and enforced by Ravimiamet (State Agency of Medicines), which issues wholesale, manufacturing and pharmacy activity licences and runs the national medicines register. |
|---|---|
| Ravimiamet's stated position on research-labelled peptides | A dated (19 June 2026) Ravimiamet blog post states directly that internet-sold peptides marketed for research purposes only are not intended for human use and lack reliable safety or efficacy data; it names BPC-157, TB-500, CJC-1295 and ipamorelin as commonly seen examples and stresses that personal anecdotes do not substitute for clinical evidence. |
| GLP-1 class named directly | The same Ravimiamet post distinguishes legitimate peptide medicines - naming semaglutide and tirzepatide specifically as diabetes and weight-loss drugs used under medical supervision at defined doses - from unauthorised research-labelled peptides, the clearest primary-source regulator statement found across all four target markets. |
| Prescription-only compounds and doping angle | Somatropin appears in Estonia's own medicine statistics as a prescription pituitary hormone (ATC H01AC01); Ravimiamet's post separately flags that synthetic peptides mostly fall under WADA's prohibited list, adding a sports-doping compliance dimension for buyers. No Ravimiamet statement names Melanotan specifically. |
| Enforcement posture | Ravimiamet's posture is public-health warning rather than published seizure statistics: the peptide blog post is a consumer warning, not an enforcement notice, and no takedown or seizure figures for peptide sellers were found on ravimiamet.ee. |
| Already supplying Estonia? Send the compounds and volumes you buy today and we will quote against them. | Send your list |
Your obligations
What a buyer in Estonia needs settled
- Apply to Ravimiamet for a ravimite hulgimuugi tegevusluba (medicinal products wholesale activity licence) and the accompanying GDP certificate before importing or reselling medicinal products; roughly 65 companies held this licence in Estonia in 2025.
- Do not use a research-use-only label to sidestep Estonian medicines law: Ravimiamet's own June 2026 warning states such products are not intended for human use, implying any human-use marketing would trigger the medicines regime regardless of label.
- Assume semaglutide and tirzepatide is regulated prescription medicines requiring medical supervision, per Ravimiamet's explicit framing, not as generic research compounds.
- Flag doping-status exposure for peptide compounds (BPC-157, TB-500, CJC-1295, ipamorelin, etc.) since Ravimiamet links them to WADA's prohibited list, relevant to any B2B customer in sport-adjacent retail.
We will ask about this at enquiry. We check the authorisations your activity requires before quoting, and we confirm the position per compound rather than for the market as a whole.
Sources
Check this yourself
Every position above traces to a dated public document. The authority, the document, the date and the link are below.
| Authority and document | Date | Link |
|---|---|---|
| Ravimiamet Ravimiamet hoiatab: Internetis muudavad peptiidid voivad ohustada tervist | 2026-06-19 | www.ravimiamet.ee/blogi/ravimiamet-hoiatab-internetis-muud... |
| Ravimiamet Hulgimuuk (wholesale distribution licence page) | page last updated 2025-05-30 | www.ravimiamet.ee/ravimid-ja-ohutus/ravimi-kaitlemine/hulg... |
Links go to the issuing body wherever one exists. Positions change. If you are relying on any of this, check the source rather than this page.
Market brief
Take the Estonia brief as a PDF
The regime, the buyer obligations and all 2 sources, dated and linked, in one document you can forward.
Nearby
Baltics and nearby markets
Buyers supplying one of these usually supply the others. The requirements are not the same.
| Code | Market | Sources | |
|---|---|---|---|
| LT | Lithuania | 4 sources | The VVKT regulates under the Farmacijos istatymas and requires a wholesale dis... |
| LV | Latvia | 4 sources | The ZVA regulates under the Farmacijas likums and has published dated GLP-1 sa... |
| DE | Germany | 2 sources | Germany applies the Arzneimittelgesetz alongside anti-doping legislation, and ... |
| NL | Netherlands | 3 sources | The IGJ and the NVWA assess offerings jointly and have stated their position o... |
Scope
How to use this page
A summary of the published regulatory position in Estonia as at 2026-08-20, written for procurement teams deciding how to source. Every source is dated and linked so it can be checked at origin.
It is not legal advice. Full terms of supply, including where responsibility sits, are set out in our terms of supply.
Questions
Supplying into Estonia
Do you supply into Estonia?
We supply businesses that hold the authorisations their activity requires. Whether a specific compound can be supplied into Estonia depends on that compound and on your authorisations, and we confirm it per compound at the enquiry stage.
Who carries the compliance obligation?
The importer of record and the party placing the product on the market, which is the buyer. We supply the batch documentation that supports your file. We cannot hold your authorisations for you.
How current is this page?
It was reviewed on 2026-08-20 and is scheduled for review again on 2026-11-18. Every source is dated and linked, so you can check the original.
We already supply into Estonia. What changes if we source from you?
The batch documentation. You receive a Certificate of Analysis per batch, which can be issued under your own brand. The import and market-placing responsibilities stay where they are.
Is this legal advice?
No. It is a summary of the regulatory positions those authorities have published, as at the review date above. Take advice in your own market before you rely on it.
Enquire about supply into Estonia
Tell us the compounds and your authorisations. We confirm per compound before anything ships.